Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 6 (2009), Issue 7 (July)

1. Myelin water imaging: Implementation and development at 3.0T and comparison to 1.5T measurements.
   Magn Reson Med, 62(1): 106-15. [Abstract] [Full-text]
2. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS.
   Genes Dev, 23(13): 1571-85. [Abstract] [Full-text]
3. Cognitive reserve moderates the negative effect of brain atrophy on cognitive efficiency in multiple sclerosis.
   J Int Neuropsychol Soc, 15(4): 606-12. [Abstract] [Full-text]
4. MR spectroscopy (MRS) and magnetisation transfer imaging (MTI), lesion load and clinical scores in early relapsing remitting multiple sclerosis: a combined cross-sectional and longitudinal study.
   Eur Radiol, 19(8): 2066-74. [Abstract] [Full-text]
5. Glioblastoma in multiple sclerosis: a case report.
   J Neurooncol, 94(1): 141-4. [Abstract] [Full-text]
6. Cerebrospinal fluid biomarkers in multiple sclerosis.
   Neurobiol Dis, 35(2): 117-27. [Abstract] [Full-text]
7. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis.
   Glia, 57(11): 1192-203. [Abstract] [Full-text]
8. Endothelial NOS-deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitis.
   Glia, 57(11): 1204-15. [Abstract] [Full-text]
9. Effectiveness of applying progressive muscle relaxation technique on quality of life of patients with multiple sclerosis.
   J Clin Nurs, 18(15): 2171-9. [Abstract] [Full-text]
10. IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H).
    J Clin Invest, 119(7): 2052-61. [Abstract] [Full-text]
11. Treatment of seizures in multiple sclerosis.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
12. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
13. Investigation of quantitative magnetisation transfer parameters of lesions and normal appearing white matter in multiple sclerosis.
    NMR Biomed, 22(6): 646-53. [Abstract] [Full-text]
14. Refining an automatic EDSS scoring expert system for routine clinical use in multiple sclerosis.
    IEEE Trans Inf Technol Biomed, 13(4): 501-11. [Abstract] [Full-text]
15. Headaches in the different phases of relapsing-remitting multiple sclerosis: a tendency for stabbing headaches during relapses.
    Neurologist, 15(4): 212-6. [Abstract] [Full-text]
16. Adherence of adolescents to multiple sclerosis disease-modifying therapy.
    Pediatr Neurol, 41(2): 119-23. [Abstract] [Full-text]
17. Prevention of orthogonal array of particles formation as a treatment approach for neuromyelitis optica.
    Med Hypotheses, 73(3): 361-2. [Abstract] [Full-text]
18. The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial.
    J Neurol, 256(7): 1095-102. [Abstract] [Full-text]
19. Clinical predictors of early second event in patients with clinically isolated syndrome.
    J Neurol, 256(7): 1061-6. [Abstract] [Full-text]
20. Is the risk of multiple sclerosis related to the 'biography' of the immune system?
    J Neurol, 256(7): 1052-60. [Abstract] [Full-text]
21. MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof's criteria but different lesion patterns.
    J Neurol, 256(7): 1121-5. [Abstract] [Full-text]
22. Smoking and disease progression in multiple sclerosis.
    Arch Neurol, 66(7): 858-64. [Abstract] [Full-text]
23. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Arch Neurol, 66(7): 841-6. [Abstract] [Full-text]
24. Emerging therapies for relapsing multiple sclerosis.
    Arch Neurol, 66(7): 821-8. [Abstract] [Full-text]
25. Endogenous remyelination is induced by transplant rejection in a viral model of multiple sclerosis.
    J Neuroimmunol, 212(1): 74-81. [Abstract] [Full-text]
26. Antibodies against interferon-beta in multiple sclerosis.
    J Neuroimmunol, 212(1): 148-50. [Abstract] [Full-text]
27. The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds.
    J Neuroimmunol, 212(1): 121-4. [Abstract] [Full-text]
28. Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1.
    J Neuroimmunol, 212(1): 125-31. [Abstract] [Full-text]
29. Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year longitudinal study.
    J Neuroimmunol, 212(1): 112-20. [Abstract] [Full-text]
30. Variants in ST8SIA1 do not play a major role in susceptibility to multiple sclerosis in Canadian families.
    J Neuroimmunol, 212(1): 142-4. [Abstract] [Full-text]
31. IFNbeta therapy progressively normalizes the increased ex vivo T lymphocyte apoptosis observed in active patients with multiple sclerosis.
    Clin Immunol, 132(2): 195-202. [Abstract] [Full-text]
32. Possible role of receptor heteromers in multiple sclerosis.
    J Neural Transm, 116(8): 989-94. [Abstract] [Full-text]
33. Early contrast-enhanced magnetic resonance imaging with fluid-attenuated inversion recovery in multiple sclerosis.
    J Neuroimaging, 19(3): 246-9. [Abstract] [Full-text]
34. Neuromyelitis optica preceded by brain demyelinating episode.
    J Neuroimaging, 19(3): 263-5. [Abstract] [Full-text]
35. Corpus callosum damage and cognitive dysfunction in benign MS.
    Hum Brain Mapp, 30(8): 2656-66. [Abstract] [Full-text]
36. Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI study.
    Hum Brain Mapp, 30(8): 2412-25. [Abstract] [Full-text]
37. Differential micro RNA expression in PBMC from multiple sclerosis patients.
    PLoS One, 4(7): e6309. [Abstract] [Full-text]
38. Capturing the costs of end-of-life care: comparisons of multiple sclerosis, Parkinson's disease, and dementia.
    J Pain Symptom Manage, 38(1): 62-7. [Abstract] [Full-text]
39. Secretory phospholipase A2-IID is an effector molecule of CD4+CD25+ regulatory T cells.
    Proc Natl Acad Sci U S A, 106(28): 11673-8. [Abstract] [Full-text]
40. A diffusion tensor imaging group study of the spinal cord in multiple sclerosis patients with and without T2 spinal cord lesions.
    J Magn Reson Imaging, 30(1): 25-34. [Abstract] [Full-text]
41. The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective high-throughput detection by real-time PCR.
    Clin Chim Acta, 406(1): 27-30. [Abstract] [Full-text]
42. The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection.
    J Neurol Sci, 283(1): 21-7. [Abstract] [Full-text]
43. Sustained release oral fampridine in the treatment of multiple sclerosis.
    Expert Opin Pharmacother, 10(12): 2025-35. [Abstract] [Full-text]
44. Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.
    Biochem Biophys Res Commun, 386(4): 623-7. [Abstract] [Full-text]
45. Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis.
    J Psychopharmacol, 23(6): 686-96. [Abstract] [Full-text]
46. Spatiotemporal and kinematic effect of peroneal nerve stimulation versus an ankle-foot orthosis in patients with multiple sclerosis: a case series.
    PM R, 1(7): 604-11. [Abstract] [Full-text]
47. Getting the balance right: a randomised controlled trial of physiotherapy and Exercise Interventions for ambulatory people with multiple sclerosis.
    BMC Neurol, 9: 34. [Abstract] [Full-text]
48. Devic's neuromyelitis optica and pregnancy: distinction from multiple sclerosis is essential.
    Arch Gynecol Obstet, 280(3): 475-7. [Abstract] [Full-text]
49. Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why?
    Complement Ther Med, 17(4): 216-23. [Abstract] [Full-text]
50. Antibodies against a class II HLA-peptide complex raised by active immunization of mice with antigen mimicking peptides.
    Scand J Immunol, 70(2): 93-100. [Abstract] [Full-text]
51. Age of onset in concordant twins and other relative pairs with multiple sclerosis.
    Am J Epidemiol, 170(3): 289-96. [Abstract] [Full-text]
52. Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis.
    J Virol Methods, 161(1): 98-106. [Abstract] [Full-text]
53. Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis.
    Brain Res, 1283: 177-85. [Abstract] [Full-text]
54. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies.
    Neurology, 73(4): 302-8. [Abstract] [Full-text]
55. Apolipoprotein E polymorphism interacts with cigarette smoking in progression of multiple sclerosis.
    Eur J Neurol, 16(7): 832-7. [Abstract] [Full-text]
56. The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis.
    Health Qual Life Outcomes, 7: 68. [Abstract] [Full-text]
57. A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome.
    Eur Radiol, 19(9): 2244-8. [Abstract] [Full-text]
58. Signal abnormalities on 1.5 and 3 Tesla brain MRI in multiple sclerosis patients and healthy controls. A morphological and spatial quantitative comparison study.
    Neuroimage, 47(4): 1352-62. [Abstract] [Full-text]

© 2004-2012 Multiple Sclerosis Research Today. All Rights Reserved.